Catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options.
We used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia.
Learn more about Our Hemophilia Program.
A protease is an enzyme that cleaves target proteins. Learn more about Proteases.